44 filings
8-K
HUMA
Humacyte Inc
22 Mar 24
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
7:06am
8-K
HUMA
Humacyte Inc
4 Mar 24
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
6:53am
8-K
HUMA
Humacyte Inc
29 Feb 24
Other Events
4:02pm
8-K
HUMA
Humacyte Inc
9 Feb 24
Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
8:06am
8-K
HUMA
Humacyte Inc
12 Dec 23
Other Events
8:06am
8-K
tvrvske0kmo
9 Nov 23
Humacyte Third Quarter 2023 Financial Results and Business Update
4:07pm
8-K
gj3x5ww4eqj2ofgkb8uf
12 Sep 23
Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) in Treatment of Patients with Vascular Trauma
7:09am
8-K
2npeaetdt lajbz7
14 Aug 23
Humacyte Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
0bd3lfz7k779vh7
26 Jul 23
Humacyte Completes Enrollment in Phase 2/3 Trial of
8:07am
8-K
lae nbgkk
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
c4vymojlr r34ldge
12 May 23
Humacyte First Quarter 2023 Financial Results and Business Update
7:13am
8-K
6ypjec0x9f 1rl30
24 Mar 23
Humacyte Announces Fourth Quarter and Year End 2022 Financial Results and Business Update
7:04am
8-K
946l3zrfxx0nc97m
13 Mar 23
Regulation FD Disclosure
8:00am
8-K
fhfcp23
12 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
j3p0jlk
10 Nov 22
Humacyte Third Quarter 2022 Financial Results and Business Update
7:04am
8-K
e57m6x74x5u8pvh25
20 Sep 22
Humacyte Expands Board of Directors and Leadership Team with New Appointments
4:06pm
8-K
uh0udjqqybwzal
12 Aug 22
Humacyte Second Quarter 2022 Financial Results and Business Update
7:04am
8-K
rp4gnd36
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
itwvl9v
13 May 22
Humacyte First Quarter 2022 Financial Results and Business Update
7:03am
8-K
vl3wj6nq
29 Mar 22
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
7:04am